SYSTEMATIC FINANCIAL MANAGEMENT LP - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
SYSTEMATIC FINANCIAL MANAGEMENT LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2020$340,000
-31.6%
120,410
-21.3%
0.02%
+10.5%
Q4 2019$497,000
-8.3%
153,020
-39.0%
0.02%
-20.8%
Q3 2019$542,000
-36.9%
250,935
-8.2%
0.02%
-27.3%
Q2 2019$859,000
-35.5%
273,425
-23.6%
0.03%
-28.3%
Q1 2019$1,332,000
+10.1%
357,980
-14.2%
0.05%
+24.3%
Q4 2018$1,210,000
-23.8%
417,200
-30.9%
0.04%
-2.6%
Q3 2018$1,587,000
+36.8%
603,460
+21.7%
0.04%
+35.7%
Q2 2018$1,160,000
-30.5%
495,850
-12.7%
0.03%
-24.3%
Q1 2018$1,669,000
+1.5%
567,795
-5.5%
0.04%
+12.1%
Q4 2017$1,645,000
-2.7%
600,525
+20.4%
0.03%
-2.9%
Q3 2017$1,691,000
-4.2%
498,830
-30.2%
0.03%
+3.0%
Q2 2017$1,765,000
+9.2%
714,640
+0.4%
0.03%
+13.8%
Q1 2017$1,616,000
+6.9%
712,055
-0.1%
0.03%
+20.8%
Q4 2016$1,512,000
-15.9%
713,085
+32.9%
0.02%
-4.0%
Q3 2016$1,798,000
-3.2%
536,725
-9.3%
0.02%0.0%
Q2 2016$1,857,000
+18.2%
591,495
+25.3%
0.02%
+25.0%
Q1 2016$1,571,000
-5.6%
471,950
+0.3%
0.02%
+11.1%
Q4 2015$1,665,000
-18.4%
470,500
+15.9%
0.02%
-18.2%
Q3 2015$2,041,000
-16.5%
405,920
+6.8%
0.02%
+4.8%
Q2 2015$2,444,000
+34.0%
380,185
+75.9%
0.02%
+61.5%
Q4 2013$1,824,000
+27.6%
216,172
+20.5%
0.01%
+18.2%
Q3 2013$1,429,000
-0.1%
179,412
-3.2%
0.01%
-8.3%
Q2 2013$1,431,000185,4120.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders